Substance Abuse and PregnancyManagement of the Pregnant Substance Abusing WomanSHEEHAN, MICHAEL MD; SHEEHAN, MARY G. MDAuthor Information Operation PAR Inc., Florida Dr Michael Sheehan is a paid speaker and patient advocate for Reckitt Benckiser, manufacturer of Suboxone, and other author has no conflict of interest to disclose. Correspondence: Michael Sheehan, MD, Operation PAR Inc., 13800 66th St N, Largo, Florida 33771. E-mail: firstname.lastname@example.org Clinical Obstetrics and Gynecology: March 2013 - Volume 56 - Issue 1 - p 97-106 doi: 10.1097/GRF.0b013e3182795878 Buy Metrics Abstract Operation PAR has been involved in prevention and treatment service development for drug-dependent women for nearly 40 years. Management starts with prevention programs. For opiate-addicted pregnant women, methadone is the treatment of choice and should be maintained throughout pregnancy, despite the manageable problem of neonatal opiate withdrawal. Women are actively engaged in innovative educational and therapeutic activities to help moms build skills to enhance their personal health and develop recovery orientation and drug refusal skills. Specific parenting skills are modeled and taught both on an outpatient and inpatient basis as appropriate. © 2013 Lippincott Williams & Wilkins, Inc.